Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04683913
Other study ID # H20-03086
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date February 1, 2021
Est. completion date June 2022

Study information

Verified date May 2022
Source University of British Columbia
Contact Natasha Krowchuk, BSc
Phone 6048227948
Email natasha.krowchuk@ubc.ca
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Excessive knee joint loads during walking can contribute to knee osteoarthritis progression. Changing the rotation of the foot (in-toeing or out-toeing) while walking can lower knee joint loads and improve pain and function. Telerehabilitation (using video or telephone communication to delivery rehabilitation) has shown promise in delivering exercise therapy for knee osteoarthritis, but it is unknown if walking modifications can be delivered using this method. This study consists of a six-week walking modification program in people with knee osteoarthritis. Performance of the modification will be measured using motion capture and wearable sensors during practice and daily life.


Description:

Loads on the knee joint during walking are related to worsening of knee osteoarthritis. Changing walking motions to lower these knee joint loads is an emerging management strategy for knee osteoarthritis. Multiple studies have targeted a change in the position of the foot relative to the direction of walking (toe-in or toe-out walking) and have shown this walking modification to lower knee joint loads and improve symptoms (e.g. pain) related to knee osteoarthritis within the context of a walking program. Building off the many studies that have found telerehabilitation to be an effective method of providing exercise and pain-coping physical therapy, the investigators will use this method to provide walking modification treatment. Telerehabilitation (using video or teleconferencing to conduct the physical therapy appointment) provides a convenient and cost-effective method to work with patients and coordinate their treatment plan. To monitor progress with learning the walking modification, the investigators will use a custom sensor shoe that the participants will wear during daily walking activities over the six-week intervention. Overall, this study will investigate the feasibility and effectiveness of a walking modification program delivered using video- or teleconference.


Recruitment information / eligibility

Status Recruiting
Enrollment 30
Est. completion date June 2022
Est. primary completion date May 2022
Accepts healthy volunteers No
Gender All
Age group 50 Years and older
Eligibility Inclusion Criteria: - 50 years of age or older - Exhibit signs of tibiofemoral osteoarthritis based on a score of =2 on the Kellgren and Lawrence grading scale predominantly in the medial compartment. - Self-reported knee pain = 3 / 10 on a numerical rating scale of pain (NRS; 0 = "no pain" and 10 = "worst pain imaginable") during most days of the previous month - Comfortable walking intermittently for 30 minutes - Fit into the available sizes of sensor shoes (between US women's 5 to men's 13) - Exhibits =2% reduction in knee adduction moment impulse at 10 degrees of change in toe-in or toe-out during the screening appointment. Exclusion Criteria: - Any knee surgery or intraarticular injections within the past 6 months - A history of joint replacement surgery or high tibial osteotomy - Current or recent (within 6 weeks) corticosteroid injections - Use of a gait aid - Currently on a wait list for joint replacement surgery or high tibial osteotomy - Any inflammatory arthritic condition - Any other conditions that may affect normal gait or participation in an aerobic exercise program - Cannot attend all required appointments

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Foot rotation modification
The instruction of gait modification provided via teleconferencing sessions (5 over 6 weeks) focusing on increasing toe-in or toe-out angles by "as much as is comfortable".
Other:
Waiting Period - Delayed Group
Participants allocated to the Delayed Group will wait 6 weeks after their initial baseline, then complete a second baseline to provide a control condition. After the second baseline they will enter the intervention.

Locations

Country Name City State
Canada Motion Analysis and Biofeedback Laboratory Vancouver British Columbia

Sponsors (1)

Lead Sponsor Collaborator
University of British Columbia

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Lab-measured performance of gait modification Change in foot rotation angle between baseline and both week 6 (follow-up) and week 10 (retention) appointments measured using marker-based motion capture. Foot rotation is defined as the angle between the long axis of the foot and the walking direction. Measures of central tendency and variability will be extracted. Baseline, Week 6, Week 10
Primary Real-world performance of gait modification Change in foot rotation from baseline to each real-world walking bout (represented as a single data file on the sensor module), follow-up, and retention measured via the sensor shoe. Foot rotation is defined as the angle between the long axis of the foot and the walking direction. Measures of central tendency and variability will be extracted, in addition to the proportion of steps with a greater than or equal to 7 degree change. Baseline, Week 6, Week 10
Primary Intervention adherence Adherence will be measured by the ratio of telerehabilitation sessions the participant attends relative to the total sessions (5 total). Week 6
Primary Compliance with gait modification Change in compliance will be estimated by self-reported confidence in performing the gait modification (where 0 = "no confidence" and 10 = "complete confidence") and will be assessed on a weekly basis within the diary. Acceptable confidence ratings by week 6 are greater than or equal to 7/10. Change will be compared from week 1 to week 6 and week 10. Week 1, Week 6, Week 10
Primary Difficulty in performing the modification Change in difficulty of performing the modification from week 1 to week 6 and week 10. Difficulty measured on an NRS scale (0 = no difficulty and 10 = most difficulty possible). Acceptable difficulty by week 6 is less than or equal to 4/10. Week 1, Week 6, Week 10
Primary Satisfaction with the treatment program Satisfaction with the gait modification program on a 7-point Likert scale where -3 = "extremely unsatisfied" and +3 = "extremely satisfied". Scores of +2 or +3 will be considered "satisfied" and acceptable. Baseline, Week 6
Secondary Knee-osteoarthritis related symptoms Change in pain, stiffness, physical function, and quality of life will be measured by the Knee Injury and Osteoarthritis Outcome Score at baseline, follow up and retention. Each question is rated on a 5 points Likert scale where 0 = "never" and 4 = "always". Baseline, Week 6, Week 10
Secondary Knee joint moments Change in peaks and impulse of the knee adduction moment and knee flexion moment measured via in-laboratory gait analysis (force platforms and marker-based motion capture) at baseline, follow up and retention. Baseline, Week 6, Week 10
See also
  Status Clinical Trial Phase
Recruiting NCT03895489 - Effectiveness of the Journey Total Knee Arthroplasty Versus Two Standard of Care Total Knee Arthroplasty Prostheses N/A
Completed NCT03660943 - A Clinical Study to Test Efficacy and Safety of Repeat Doses of CNTX-4975-05 in Patients With Osteoarthritis Knee Pain Phase 3
Completed NCT04531969 - Comparison of Outpatient and Inpatient Spa Therapy N/A
Completed NCT02848027 - Correlating the Osteoarthritic Knee Microenvironment to Clinical Outcome After Treatment With Regenexx®SD Treatment Phase 3
Completed NCT05160246 - The Instant Effect of Kinesiology Taping in Patients With Knee OA N/A
Recruiting NCT06080763 - Biomechanics and Clinical Outcomes in Responders and Non-Responders
Completed NCT03643588 - The Comparison of HYAJOINT Plus and Hyalgan Hyaluronan Supplement for Knee Osteoarthritis Pain N/A
Active, not recruiting NCT05100225 - Efficacy and Safety Trial of PTP-001 (MOTYS) for Symptomatic Knee Osteoarthritis Phase 2
Active, not recruiting NCT04061733 - New Hydroxyethyl Cellulose Hydrogel for the Treatment of the Pain of Knee Arthrosis N/A
Completed NCT04051489 - A Novel Smartphone Application for "Smart" Knee Osteoarthritis Trials
Recruiting NCT05546541 - Epidemiology and Nutrition
Recruiting NCT05447767 - Prediction AlgoriThm for regeneraTive Medicine Approach in knEe OA: New Decision-making Process Based on Patient pRofiliNg Phase 2
Not yet recruiting NCT04448106 - Autologous Adipose Tissue-Derived Mesenchymal Stem Cells (AdMSCs) for Osteoarthritis Phase 2
Not yet recruiting NCT03225911 - Effect of a Lateral Wedge Insole and Simple Knee Sleeve in Individuals With Knee Osteoarthritis N/A
Completed NCT05070871 - A Clinical Trial Investigating the Effect of Salmon Bone Meal on Osteoarthritis Among Men and Women N/A
Completed NCT05703087 - Positive Cueing in Knee Arthroplasty. N/A
Not yet recruiting NCT06042426 - Effects of Perioperative Intravenous Dexamethasone in Clinical Outcomes After Total Knee Arthroplasty in a Hispanic Population Phase 4
Not yet recruiting NCT02826850 - Saphenous Nerve Radiofrequency for Knee Osteoarthritis Trial Phase 3
Completed NCT02944448 - A Study Evaluating Pain Relief and Safety of Orally Administered CR845 in Patients With Osteoarthritis of Hip or Knee Phase 2
Terminated NCT02909257 - Motor-Sparing Femoral Nerve Block Dose Phase 4